T1	Participants 84 143	men with signs and symptoms of benign prostatic hyperplasia
T2	Participants 372 577	Men 50 years or older with an International Prostate Symptom Score of 13 or greater and peak urinary flow rate of 4 to 15 ml per second received placebo or 8 mg silodosin daily with breakfast for 12 weeks.
T3	Participants 813 845	923 patients (mean age 65 years)
